Indefinite Delivery Contract SPE2DX22D0119

This is an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, serves as the primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Under this IDC, AmerisourceBergen has received numerous delivery orders, ranging from approximately $1,000 to over $65,000, to deliver these medical products to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract does not have any set-aside designations, indicating open competition. AmerisourceBergen also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, demonstrating its broad role as a key vendor for federal healthcare programs.

The original solicitation was a Special Notice published by the DLA Medical Directorate seeking industry feedback on a draft Statement of Work for the upcoming National Prime Vendor Generation IV contract. This contract is intended to support the Defense Health Agency's TRICARE Pharmacy Program by providing replenishment of pharmaceutical and related products to multiple TRICARE pharmacy ordering facilities, as well as readiness support and backup to CONUS pharmaceutical prime vendors. The contract term is one base period and one option period not exceeding five years, with pricing based on Federal Supply Schedule, DAPA, or regional DAPA prices plus the contractor's distribution fee and Cost Recovery Rate.